$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卡博替尼用于接受过索拉非尼治疗的肝癌患者
2025-10-19 11:44:20
Check Details
多吉美与一些药物的相互作用
2025-10-19 11:44:20
Check Details
多吉美治疗效果有多好
2025-10-19 11:44:20
Check Details
多吉美真假辨别小妙招
2025-10-19 11:44:20
Check Details
癌症克星多吉美
2025-10-19 11:44:20
Check Details
这几种药物和多吉美同服需谨慎
2025-10-19 11:44:20
Check Details
两款多吉美如何选择?
2025-10-19 11:44:20
Check Details
晚期肝癌延缓药——多吉美
2025-10-19 11:44:20
Check Details
辨别多吉美真假的小窍门
2025-10-19 11:44:20
Check Details
多吉美治疗肝癌疗效如何?
2025-10-19 11:44:20
Check Details
服用多吉美有出血可能
2025-10-19 11:44:20
Check Details
相比安慰剂,多吉美治疗丙肝更有效
2025-10-19 11:44:20
Check Details
1
2
...
2582
2583
2584
2585
2586
2587
2588
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
2
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
3
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
4
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
9
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
10
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
11
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
12
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?